1 completed, 1 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow 400 mg Cannabidiol: new trials by email Literature Review of 400 mg Cannabidiol trials Research Report on 400 mg Cannabidiol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabidiol in Opioid Use Disorder and Chronic Pain 400 mg Cannabidiol, 800 mg Cannabidiol, 1200 mg Cannabidiol - Chronic Pain, Opioid Use Disorder | Early Phase 1 | Completed | Yale University | 23 | 2021-12-08 | 2026-10-13 |
| Cannabidiol in Opioid Use Disorder and Chronic Pain With Buprenorphine 400 mg Cannabidiol, 800 mg Cannabidiol, 1200 mg Cannabidiol - Chronic Pain, Opioid Use Disorder | Early Phase 1 | Recruiting | Yale University | 34 | 2021-12-08 | 2026-10-21 |
Chronic Pain (2) · Opioid-Related Disorders (2) · Pain (2)
Yale University (2)
United States (2)
K23DA052682 (1)